Diagnostic Values of Serum Procalcitonin in Kidney Diseases
Journal of Pediatric Nephrology,
Vol. 3 No. 1 (2015),
10 January 2015
,
Page 7-12
https://doi.org/10.22037/jpn.v3i1.7813
Abstract
Many clinical studies have confirmed Procalcitonin (PCT) as a specific inflammatory marker in sepsis and bacterial infections. It is believed that PCT level is increased in various noninfectious conditions such as acute pancreatitis, major surgery, trauma and active autoimmune disease. In recent studies increased levels of serum PCT was distinguished in several kidney diseases like pyelonephritis, vesicoureteral reflux, kidney transplantation and hemodialysis. The aim of this review is to describe usefulness of PCT and practical aspect of this biomarker in nephrology field.
Keywords: Procalcitonin; Biomarker; Pyelonephritis; Kidney Diseases; Kidney Transplantation; Vesico-Ureteral reflux.How to Cite
References
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical Pharmacology and Therapeutics. 2001;69(3):89–95.
Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515–8.
Russwurm S, Wiederhold M, Oberhoffer M, Stonans I, Zipfel P, Reinhart K. Molecular aspects and natural source of procalcitonin Clin Chem Lab Med1999;37:789-97.
Al-Nawas B, Krammer I, Shah PM. Procalcitonin in diagnosis of severe infections. Eur J Med Res 1996;1:331-3.
Muller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001;86: 396–404.
Russwurm S, Stonans I, Stonane E et al. Procalcitonin and CGRP-I mRNA expression in various human tissues. Shock 2001;16: 109–12.
Whang KT, Steinwald PM, White JC et al. Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab 1998;83: 3296–301. 4
Muller B, Becker KL, Schächinger H, Rickenbacher PR, Zimmerli W, Ritz R. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000;28:977–83.
Nylen ES, O’Neill W, Jordan MH, Snider RH, Moore CF, Lewis M, et al. Serum procalcitonin as an index of inhalation injury in burns. 1992;24:439–43.
Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis. Clin Infect Dis. (2004) 39 (2): 206-217.
Nijsten MW, Olinga P, The TH, et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000;28:458-61.
Oberhoffer M, Stonans I, Russwurm S, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 1999;134:49-55.
Wagner KE, Martinez JM, Vath SD et al. Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigs. Crit Care Med 2002;30: 2313–21.
Hoffmann G, Czechowski M, Schloesser M, Schobersberger W. Procalcitonin amplifies inducible nitric oxide synthase gene expression and nitric oxide production in vascular smooth muscle cells. Crit Care Med 2002;30: 2091–5.
Wagner KE, Martinez JM, Vath SD et al. Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigs. Crit Care Med 2002;30: 2313–21.
Wiedermann FJ, Kaneider N, Egger P et al. Migration of human monocytes in response to procalcitonin. Crit Care Med 2002;30: 1112–7.
Monneret G, Arpin M, Venet F et al. Calcitonin gene related peptide and N-procalcitonin modulate CD11b upregulation in lipopolysaccharide activated monocytes and neutrophils. Intensive Care Med 2003;29: 923–8.
Kylanpa-Back ML, Takala A, Kemppainen EA et al. Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit Care Med 2001;29: 63–9.
Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998;24: 680–4.
Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 2000;28: 950–7.
Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease and invasive bacterial infection. Arthritis Rheum 1997;40: 1250–6.
Castelli GP, Pognani C, Meisner M et al. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 2004;8: R234–R242.
Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003;31: 1737–41.
Benador N, Anne Siegrist C, Gendrel D, et al. Procalcitonin Is a Marker of Severity of Renal Lesions in Pyelonephritis Pediatrics 1998;102(6):1422 -1425.
Gervaix A, Galetto A, Gueron T, et al. Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection. Pediatric Infectious Disease Journal 2001;20(5):507-511.
Pecile P, Miorin E, Romanello C, et al. Procalcitonin: A Marker of Severity of Acute Pyelonephritis Among Children. Pediatrics 2004;114(2):249 -254.
Smolkin V, Koren A, Raz R, Colodner R, Sakran W, Halevy R. Procalcitonin as a marker of acute pyelonephritis in infants and children. Pediatric Nephrology 2002;17(6):409-412.
Prat C, Dominguez G, Rodrigo C, et al. elevated serum PCT levels correlate with renal scarring in children with UTI. Ped Inf Dis J 2003;22:438-42.
Tuerlinckx D, Vander Borght T, Glupczynski Y, et al. Is procalcitonin a good marker of renal lesion in febrile urinary tract infection? uropean Journal of Pediatrics 2005;164(10):651-652.
Mantadakis E. Plessa E, Vouloumanou E. Karageorgopoulos D, Chatzimichael A, Falagas M. Procalcitonin for Prediction of Renal Parenchymal Involvement in Children with Urinary Tract Infections: A Meta-analysis of Prospective Clinical Studies. The j of Pediatrics 2009;155(6):875–881.
Leroy S, Romanello C, Galetto-Lacour A, et al. Procalcitonin to Reduce the Number of Unnecessary Cystographies in Children with a Urinary Tract Infection: A European Validation Study. The J of Pediatrics 2007;150(1):89–95.
Leroy S, Adamsbaum C, Marc E, et al. Procalcitonin as a Predictor of Vesicoureteral Reflux in Children with a First Febrile Urinary Tract Infection. Pediatrics 2005;115(6):706 -709.
Schmidt M, Burchardi C, Sitter T, Held E, Schiffl H. Procalcitonin in patients undergoing chronic hemodialysis. Nephron 2000;84: 187–8. 18
Level C, Chauveau P, Delmas Y et al. Procalcitonin: a new marker of inflammation in haemodialysis patients? Nephrol Dial Transplant 2001;16: 980–6. 19
Dahaba AA, Rehak PH, List WF. Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis. Intensive Care Med 2003;29: 579–83
Shlipak MG, Fried LF, Crump C et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003;107: 87–92.
Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 2003;63: 654–61.
Mann JF, Gerstein HC, Pogue J et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001;134: 629–36.
Oberhoffer M, Stonans I, Russwurm S et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 1999;134: 49–55.
Balog A, Ocsovszki I, Mandi Y. Flow cytometric analysis of procalcitonin expression in human monocytes and granulocytes. Immunol Lett 2002;84: 199–203.
Oberhoffer M, Vogelsang H, Jager L, Reinhart K. Katacalcin and calcitonin immunoreactivity in different types of leukocytes indicate intracellular procalcitonin content. J Crit Care 1999;14: 29–33.
Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Muller B. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 2004;32: 1715–21.
Herget-Rosenthal S, Marggraf G, Pietruck F et al. Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant 2001;16: 975–9.
Sitter T, Schmidt M, Schneider S, Schiffl H. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin. J Nephrol 2002;15: 297–301.
Mori K, Noguchi M, SuminoY, Sato F, Mimata H. Use of Procalcitonin in Patients on Chronic Hemodialysis: Procalcitonin Is Not Related with Increased Serum Calcitonin. ISRN Urology 2012;431859:6 pages
Herget-Rosenthal S, Klein T, Marggraf G, et al. Modulation and Source of Procalcitonin in Reduced Renal Function and Renal Replacement Therapy. Scandinavian Journal of Immunology 2005;61(2)180–186.
Descamps-Latscha B, Jungers P, Witko-Sarsat V. Immune system dysregulation in uremia: role of oxidative stress. Blood Purif 2002;20: 481–4.
Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial 2002;15: 329–37.
Visvardis G, Griveas L, Fleva A, et al. Relevance of Procalcitonin Levels in Comparison to Other Markers of Inflammation in Hemodialysis Patients. Renal failure 2005;27(4):429-434.
Chauveau P, Level C, Lasseur C, et al. C-reactive protein and procalcitonin as markers of mortality in hemodialysis patients: A 2-year prospective study. Journal of Renal Nutrition 2003;13(2):137–143.
Conti G, Amore A, Chiesa M. Procalcitonin as a marker of micro-inflammation in hemodialysis. J EPHROL 2005; 18: 282-288.
Herget‐Rosenthal S, Marggraf G, Pietruck F, et al. Procalcitonin for accurate detection of infection in haemodialysis. Pediatric Nephrology 2007;22:430-435.
Dahaba A, Rehak P, List WF. Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis. Journal of Renal Nutrition 2003;13(2):137–143.
Lorton F, Veinberg F, Ielsch D, Deschênes G, Bensman A, UlinskiT. Procalcitonin serum levels in children undergoing chronic haemodialysis. Pediatric Nephrology 2007;22(3):430-435.
Sitter T, Schmidt M, Schneider S, Schiffl H. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin. Journal of Nephrology 2002;15(3):297-301.
Kalocheretis P, Revela L, Spanou E, Drouzas A, Makriniotou L, Iatrou C. Strong Correlation of B2-Microglobulin (B2-m) with Procalcitonin (PCT) in the Serum of Chronic Hemodialysis Patients: A Role for Infections in the Dialysis-Related Amyloidosis? Renal failure 2008;30(3):261-265.
Eberhard OK, Langefeld I, Kuse ER, et al. Procalcitonin in the early phase after renal transplantation--will it add to diagnostic accuracy? Clinical Transplantation1998, 12(3):206-211.
Jarešová M, Střı́ž I, Čermáková J, et al. Serum procalcitonin concentrations in transplant patients with acute rejection and bacterial infections. Immunology Letters 1999;69(3):355–358.
Sabat R, C. Höflich C, Döcke WD, et al. Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies. Intensive Care Medicine 2001;27(6):987-991.
Da-Yeon Jung, Jae Berm Park, Eun-Na Lee, et al. Combined use of myeloid-related protein 8/14 and procalcitonin as diagnostic markers for acute allograft rejection in kidney transplantation recipients. Transplant Immunology 2008;18(4):338-343.
- Abstract Viewed: 403 times
- PDF Downloaded: 5353 times